Global Clinical Trial Imaging Market Size, Status and Forecast 2022-2028
Market Analysis and Insights: Global Clinical Trial Imaging Market
The global Clinical Trial Imaging market size is projected to reach US$ 2197.88 million by 2028, from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028.
Fully considering the economic change by this health crisis, In-house Imaging Service accounting for 30.61% of the Clinical Trial Imaging global market in 2021, is projected to value US$ 598.79 million by 2028, growing at a revised 5.05% CAGR between 2022 and 2028. While Pharmaceutical Companies segment is altered to an 7.33% CAGR throughout this forecast period.
China Clinical Trial Imaging market size was US$ 136.53 million in 2021, while the North America and Europe Clinical Trial Imaging were US$ 459.63 million and US$ 374.96 million, severally. The proportion of the North America was 33.32% in 2021, while China and Europe were 9.90% and 27.18% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 8.54% through the analysis period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trial Imaging market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trial Imaging market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial Imaging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial Imaging market.
Global Clinical Trial Imaging Scope and Market Size
Clinical Trial Imaging market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
Clario
ICON
McLaren
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Southeast Asia
Korea
Australia
Rest of Asia
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
South Africa
Rest of MEA
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook